NTRBW

Nutriband Inc.

Price Chart

Latest Quote

$1.21

+0.00 (+0.00%)

Current Price

Previous Close	$1.21
Open	$2.61
Day High	$1.21
Day Low	$1.21
Volume	110

Fetched: 2026-06-23T21:31:32

Stock Information

Total Debt	$233K
Cash Equivalents	$4.01M
Revenue	$1.80M
Net Income	$-29.90M
EPS (TTM)	$-0.51
Exchange	NCM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Sales	$1.80M
Income	$-29.90M
Book/sh	$0.49

Financial Ratios

Quick Ratio	4.82
Current Ratio	5.26
Debt/Eq	3.88

Returns & Margins

ROA	-78.18%
ROE	-145.72%
Gross Margin	28.36%
Operating Margin	-289.42%

Ownership

Insider & Institutional transactions data not available

Valuation Ratios

P/B

2.45

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$1.01
SMA50	$1.15
SMA200	$1.50
RSI	100.00
ATR	0.0393

Shares Float	5.28M
Volatility	1.93

Performance History

Week	+34.44%
Month	-4.72%
Quarter	-22.68%
6 Months	-18.24%
YTD	-24.84%
Year	-36.32%
3 Years	-10.37%
10 Years	-16.55%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-22	$1.21	0
2026-06-18	$1.21	0
2026-06-17	$1.21	0
2026-06-16	$1.21	5,000
2026-06-15	$0.90	0
2026-06-12	$0.90	0
2026-06-11	$0.90	0
2026-06-10	$0.90	8,100
2026-06-09	$0.90	0
2026-06-08	$0.90	0
2026-06-05	$0.90	0
2026-06-04	$0.90	0
2026-06-03	$0.90	100
2026-06-02	$0.85	200
2026-06-01	$0.85	3,700
2026-05-29	$0.90	2,000
2026-05-28	$1.00	2,800
2026-05-27	$1.15	0
2026-05-26	$1.15	100

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

📰 Latest News

Nutriband Second Quarter 2026 Earnings: Misses Expectations

Simply Wall St. • 2025-09-11T10:20:28Z

Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates

Zacks • 2025-09-09T22:45:02Z

Nutriband's (NASDAQ:NTRB) investors will be pleased with their favorable 37% return over the last three years

Simply Wall St. • 2025-08-22T19:28:37Z

Period:

Income Statement (Annual)

Metric	2026-01-31	2025-01-31	2024-01-31	2023-01-31
Revenue
Reconciled Cost Of Revenue	$1,470,343	$1,396,220	$1,223,209	$1,329,200
Cost Of Revenue	$1,470,343	$1,396,220	$1,223,209	$1,329,200
Total Revenue	$2,036,651	$2,139,537	$2,085,314	$2,079,609
Operating Revenue	$2,036,651	$2,139,537	$2,085,314	$2,079,609
Expenses
Interest Expense	$22,535	$21,407	$75,815	$8,289
Total Expenses	$10,354,612	$8,829,164	$6,957,240	$6,227,468
Other Income Expense	$110,864	$-3,771,583	$-554,423	$-327,326
Other Non Operating Income Expenses	$110,864	$191,669	-	-
Net Non Operating Interest Income Expense	$-22,535	$-21,407	$-58,965	$-8,289
Interest Expense Non Operating	$22,535	$21,407	$75,815	$8,289
Operating Expense	$8,884,269	$7,432,944	$5,734,031	$4,898,268
General And Administrative Expense	-	-	-	-
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Net Interest Income	$-22,535	$-21,407	$-58,965	$-8,289
Normalized Income	$-8,229,632	$-6,519,365	$-4,930,891	$-4,156,148
Net Income From Continuing And Discontinued Operation	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Total Operating Income As Reported	$-8,317,961	$-10,284,843	$-4,871,926	$-4,475,185
Net Income Common Stockholders	$-30,043,798	$-10,482,617	$-5,485,314	$-4,483,474
Net Income	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Net Income Including Noncontrolling Interests	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Net Income Continuous Operations	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Pretax Income	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Special Income Charges	$0	$-3,963,252	$-554,423	$-327,326
Operating Income	$-8,317,961	$-6,689,627	$-4,871,926	$-4,147,859
Gross Profit	$566,308	$743,317	$862,105	$750,409
Interest Income	-	$191,669	$16,850	$0
Interest Income Non Operating	-	$191,669	$16,850	$0
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-8,013,300	$-6,212,904	$-4,567,354	$-3,817,716
Total Unusual Items	$0	$-3,963,252	$-554,423	$-327,326
Total Unusual Items Excluding Goodwill	$0	$-3,963,252	$-554,423	$-327,326
Reconciled Depreciation	$193,797	$285,054	$287,722	$330,143
EBITDA (Bullshit earnings)	$-8,013,300	$-10,176,156	$-5,121,777	$-4,145,042
EBIT	$-8,207,097	$-10,461,210	$-5,409,499	$-4,475,185
Diluted NI Availto Com Stockholders	$-30,043,798	$-10,482,617	$-5,485,314	$-4,483,474
Preferred Stock Dividends	$21,814,166	-	-	-
Tax Provision	$0	$0	$0	$0
Impairment Of Capital Assets	$0	$3,595,216	$0	$327,326
Research And Development	$1,891,129	$3,119,134	$1,960,425	$982,227
Selling General And Administration	$6,993,140	$4,313,810	$3,773,606	$3,916,041
Other Special Charges	-	$368,036	$554,423	-
Otherunder Preferred Stock Dividend	-	-	-	$0
Other Gand A	-	-	-	-

Fetched: 2026-06-22

Balance Sheet (Annual)

Metric	2026-01-31	2025-01-31	2024-01-31	2023-01-31
Assets
Net Tangible Assets	$4,759,526	$4,448,278	$749,242	$2,770,847
Total Assets	$7,547,935	$7,469,955	$7,517,154	$9,456,377
Total Non Current Assets	$2,559,217	$2,675,690	$6,495,291	$6,762,632
Goodwill And Other Intangible Assets	$1,919,962	$1,980,627	$5,688,993	$5,802,143
Other Intangible Assets	$200,427	$261,092	$667,280	$780,430
Current Assets	$4,988,718	$4,794,265	$1,021,863	$2,693,745
Prepaid Assets	$177,470	$196,658	$211,667	$365,925
Inventory	$117,987	$212,041	$168,605	$229,335
Receivables	$118,404	$73,847	$148,649	$113,045
Accounts Receivable	$118,404	$73,847	$148,649	$113,045
Cash Cash Equivalents And Short Term Investments	$4,574,857	$4,311,719	$492,942	$1,985,440
Cash And Cash Equivalents	$4,574,857	$4,311,719	$492,942	$1,985,440
Debt
Total Debt	$245,490	$186,349	$241,285	$185,805
Long Term Debt And Capital Lease Obligation	$84,166	$58,205	$79,826	$134,774
Long Term Debt	$35,861	$58,205	$79,826	$100,497
Current Debt And Capital Lease Obligation	$161,324	$128,144	$161,459	$51,031
Current Debt	$128,871	$128,144	$127,183	$19,740
Other Current Borrowings	$128,871	$128,144	$127,183	$19,740
Liabilities
Total Liabilities Net Minority Interest	$868,447	$1,041,050	$1,078,919	$883,387
Total Non Current Liabilities Net Minority Interest	$84,166	$58,205	$79,826	$134,774
Current Liabilities	$784,281	$982,845	$999,093	$748,613
Current Deferred Liabilities	$120,303	$155,880	$157,502	$162,903
Payables And Accrued Expenses	$502,654	$698,821	$680,132	$534,679
Current Notes Payable	-	-	$0	$0
Equity
Common Stock Equity	$6,676,479	$6,428,905	$6,438,235	$8,572,990
Preferred Stock Equity	$3,009	-	-	-
Total Equity Gross Minority Interest	$6,679,488	$6,428,905	$6,438,235	$8,572,990
Stockholders Equity	$6,679,488	$6,428,905	$6,438,235	$8,572,990
Gains Losses Not Affecting Retained Earnings	$-304	$-304	$-304	$-304
Other Equity Adjustments	$-304	$-304	$-304	$-304
Retained Earnings	$-46,692,268	$-38,462,636	$-27,980,019	$-22,494,705
Other
Treasury Shares Number	$18,900	$32,400	$10,000	$10,000
Ordinary Shares Number	$12,155,983	$11,074,810	$8,859,870	$7,833,150
Share Issued	$12,174,883	$11,107,210	$8,869,870	$7,843,150
Tangible Book Value	$4,756,517	$4,448,278	$749,242	$2,770,847
Invested Capital	$6,841,211	$6,615,254	$6,645,244	$8,693,227
Working Capital	$4,204,437	$3,811,420	$22,770	$1,945,132
Capital Lease Obligations	$80,758	$0	$34,276	$65,568
Total Capitalization	$6,715,349	$6,487,110	$6,518,061	$8,673,487
Treasury Stock	$86,852	$148,547	$32,641	$32,641
Additional Paid In Capital	$53,443,747	$45,029,317	$34,442,339	$31,092,807
Capital Stock	$15,165	$11,075	$8,860	$7,833
Common Stock	$12,156	$11,075	$8,860	$7,833
Preferred Stock	$3,009	$0	$0	$0
Long Term Capital Lease Obligation	$48,305	-	$0	$34,277
Current Deferred Revenue	$120,303	$155,880	$157,502	$162,903
Current Capital Lease Obligation	$32,453	$0	$34,276	$31,291
Goodwill	$1,719,535	$1,719,535	$5,021,713	$5,021,713
Net PPE	$639,255	$695,063	$806,298	$960,489
Accumulated Depreciation	$-986,729	$-853,597	$-681,693	$-507,121
Gross PPE	$1,625,984	$1,548,660	$1,487,991	$1,467,610
Other Properties	$216,585	$144,585	$175,959	$207,339
Machinery Furniture Equipment	$1,409,399	$1,404,075	$1,312,032	$1,260,271
Other Inventories	$-1	-	-	-
Finished Goods	$2,815	$16,609	$8,707	-
Work In Process	$26,365	$46,255	$7,466	-
Raw Materials	$88,808	$149,177	$152,432	-

Fetched: 2026-06-22

Cash Flow Statement (Annual)

Metric	2026-01-31	2025-01-31	2024-01-31	2023-01-31
Free Cash Flow
Free Cash Flow	$-5,139,954	$-4,718,607	$-3,579,270	$-3,066,502
Operating Activities
Operating Cash Flow	$-5,134,630	$-4,626,564	$-3,527,509	$-2,987,198
Cash Flow From Continuing Operating Activities	$-5,134,630	$-4,626,564	$-3,527,509	$-2,987,198
Operating Gains Losses	-	$368,036	$554,423	$174,025
Investing Activities
Capital Expenditure	$-5,324	$-92,043	$-51,761	$-79,304
Investing Cash Flow	$-5,324	$-92,043	$-51,761	$-79,304
Cash Flow From Continuing Investing Activities	$-5,324	$-92,043	$-51,761	$-79,304
Financing Activities
Repurchase Of Capital Stock	$0	$-148,547	$0	$-119,006
Issuance Of Capital Stock	$5,305,503	$8,406,591	$0	$0
Financing Cash Flow	$5,403,092	$8,537,384	$2,086,772	$160,074
Cash Flow From Continuing Financing Activities	$5,403,092	$8,537,384	$2,086,772	$160,074
Net Common Stock Issuance	$5,305,503	$8,258,044	$0	$-119,006
Common Stock Issuance	$5,305,503	$8,406,591	$0	$0
Other
Repayment Of Debt	$-21,617	$-20,660	$-19,756	$-17,795
Issuance Of Debt	$0	$300,000	$2,106,528	$0
Interest Paid Supplemental Data	$1,250	$5,631	$7,352	$4,266
Income Tax Paid Supplemental Data	$0	$0	$0	$0
End Cash Position	$4,574,857	$4,311,719	$492,942	$1,985,440
Beginning Cash Position	$4,311,719	$492,942	$1,985,440	$4,891,868
Changes In Cash	$263,138	$3,818,777	$-1,492,498	$-2,906,428
Proceeds From Stock Option Exercised	$119,206	$0	$0	$296,875
Common Stock Payments	$0	$-148,547	$0	$-119,006
Net Issuance Payments Of Debt	$-21,617	$279,340	$2,086,772	$-17,795
Net Long Term Debt Issuance	$-21,617	$279,340	$2,086,772	$-17,795
Long Term Debt Payments	$-21,617	$-20,660	$-19,756	$-17,795
Long Term Debt Issuance	$0	$300,000	$2,106,528	$0
Net PPE Purchase And Sale	$-5,324	$-92,043	$-51,761	$-79,304
Purchase Of PPE	$-5,324	$-92,043	$-51,761	$-79,304
Change In Working Capital	$126,809	$34,088	$223,219	$-219,316
Change In Other Working Capital	$-35,577	$-1,622	$-5,401	$56,636
Change In Other Current Liabilities	$-27,242	$-34,276	$-31,292	$-36,287
Change In Payables And Accrued Expense	$120,943	$23,611	$198,893	$-104,860
Change In Prepaid Assets	$19,188	$15,009	$154,258	$4,547
Change In Inventory	$94,054	$-43,436	$60,730	$-97,687
Change In Receivables	$-44,557	$74,802	$-153,969	$-41,665
Changes In Account Receivables	$-44,557	$74,802	$-153,969	$-41,665
Other Non Cash Items	$36,000	$31,374	$31,380	$151,968
Stock Based Compensation	$2,738,396	$1,542,285	$742,696	$732,130
Asset Impairment Charge	$0	$3,595,216	$0	$327,326
Depreciation Amortization Depletion	$193,797	$285,054	$287,722	$330,143
Depreciation And Amortization	$193,797	$285,054	$287,722	$330,143
Amortization Cash Flow	$60,665	$113,150	$113,150	$146,483
Amortization Of Intangibles	$60,665	$113,150	$113,150	$146,483
Depreciation	$133,132	$171,903	$174,572	$183,660
Net Income From Continuing Operations	$-8,229,632	$-10,482,617	$-5,485,314	$-4,483,474
Provisionand Write Offof Assets	-	$0	$118,365	$0
Effect Of Exchange Rate Changes	-	-	-	$0
Gain Loss On Investment Securities	-	-	-	$174,025
Net Business Purchase And Sale	-	-	-	-
Sale Of Business	-	-	-	-

Fetched: 2026-06-22